Cargando…
Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
There is an urgent need to identify chemotherapeutic agents with improved efficacy and safety against triple-negative breast cancer (TNBC). Ginsenosides can reportedly induce tumor cell death, invasion, and metastasis; however, poor water solubility, low oral absorption rate, and rapid blood clearan...
Autores principales: | Zuo, Shuting, Wang, Jing, An, Xianquan, Wang, Zhenyu, Zheng, Xiao, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412961/ https://www.ncbi.nlm.nih.gov/pubmed/36032706 http://dx.doi.org/10.3389/fbioe.2022.945472 |
Ejemplares similares
-
Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2021) -
Janus Magnetic Nanoplatform for Magnetically Targeted and Protein/Hyperthermia Combination Therapies of Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2022) -
Efficacy analysis of targeted nanodrug for non-small cell lung cancer therapy
por: Li, Tongtong, et al.
Publicado: (2022) -
Nanodrugs systems for therapy and diagnosis of esophageal cancer
por: Zhang, Lihan, et al.
Publicado: (2023) -
Gold nanoplatform for near-infrared light-activated radio-photothermal gas therapy in breast cancer
por: Zuo, Shuting, et al.
Publicado: (2023)